Alfacalcidol and Calcitriol in the Prevention of Bone Loss after Organ Transplantation

ISSN： 0171-967X

Source： Calcified Tissue International, Vol.65, Iss.4, 1999-10, pp. : 341-343

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phenytoin-Induced Bone Loss and Its Prevention with Alfacalcidol or Calcitriol in Growing Rats

By Onodera K. Takahashi A. Mayanagi H. Wakabayashi H. Kamei J. Shinoda H.

Calcified Tissue International, Vol. 69, Iss. 2, 2001-08 ,pp. : 109-116

Springer Publishing Company

Access to resources Recommend Favorite

Calcitonin, Etidronate, and Calcidiol Treatment in Bone Loss after Cardiac Transplantation

By Garcia-Delgado I. Prieto S. Gil-Fraguas L. Robles E. Rufilanchas J. J. Hawkins F.

Calcified Tissue International, Vol. 60, Iss. 2, 1997-02 ,pp. : 155-159

Springer Publishing Company

Access to resources Recommend Favorite

Vitamin D and the D-Hormones, Alfacalcidol and Calcitriol, as Therapeutic Agents for Osteoporotic Populations

By Avioli L.

Calcified Tissue International, Vol. 65, Iss. 4, 1999-10 ,pp. : 292-294

Springer Publishing Company

Access to resources Recommend Favorite

Tacrolimus-Associated Posterior Reversible Encephalopathy Syndrome after Solid Organ Transplantation

European Neurology, Vol. 64, Iss. 3, 2010-08 ,pp. : 169-177

Karger

Access to resources Recommend Favorite

The Prevention of Corticosteroid-induced Bone Loss with Intermittent Cyclical Etidronate

By Jenkins E.A Walker-Bone K.E Wood A McCrae F.C Cooper C Cawley M.I.D

Scandinavian Journal of Rheumatology, Vol. 28, Iss. 3, 1999-05 ,pp. : 152-156

Informa Healthcare

Access to resources Recommend Favorite